<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Vargas-Alarcon G</submitter><funding>Instituto Nacional de Cardiologia Ignacio Chavez</funding><pagination>486</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9027896</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(4)</volume><pubmed_abstract>We conducted a case-control study in order to evaluate whether &lt;i>ABO&lt;/i> gene polymorphisms were associated with a high risk of developing COVID-19 in a cohort of patients. Six &lt;i>ABO&lt;/i> gene polymorphisms (rs651007 &lt;i>T&lt;/i>/&lt;i>C&lt;/i>, rs579459 &lt;i>T&lt;/i>/&lt;i>C&lt;/i>, rs495828 &lt;i>T/G&lt;/i>, rs8176746 &lt;i>A/C&lt;/i>, rs8176740 &lt;i>T/A&lt;/i>, and rs512770 &lt;i>T&lt;/i>/&lt;i>C&lt;/i>) were determined using TaqMan genotyping assays in a group of 415 COVID-19 patients and 288 healthy controls. The distribution of rs651007 &lt;i>T&lt;/i>/&lt;i>C&lt;/i>, rs579459 &lt;i>T&lt;/i>/&lt;i>C&lt;/i>, rs495828 &lt;i>T&lt;/i>/&lt;i>G&lt;/i>, and rs8176746 &lt;i>A&lt;/i>/&lt;i>C&lt;/i> polymorphisms was similar in patients and healthy controls. Nonetheless, under co-dominant (OR = 1.89, pC&lt;sub>Co-dominant&lt;/sub> = 6 × 10&lt;sup>-6&lt;/sup>), recessive (OR = 1.98, pC&lt;sub>Recessive&lt;/s</pubmed_abstract><journal>Biomolecules</journal><pubmed_title>The rs8176740 &lt;i>T/A&lt;/i> and rs512770 &lt;i>T/C&lt;/i> Genetic Variants of the &lt;i>ABO&lt;/i> Gene Increased the Risk of COVID-19, as well as the Plasma Concentration Platelets.</pubmed_title><pmcid>PMC9027896</pmcid><funding_grant_id>Project-21-1237</funding_grant_id><pubmed_authors>Ramirez-Bello J</pubmed_authors><pubmed_authors>Posadas-Sanchez R</pubmed_authors><pubmed_authors>Rojas-Velasco G</pubmed_authors><pubmed_authors>Ortega-Pena S</pubmed_authors><pubmed_authors>Arellano-Gonzalez M</pubmed_authors><pubmed_authors>Fragoso JM</pubmed_authors><pubmed_authors>Montufar-Robles I</pubmed_authors><pubmed_authors>Vargas-Alarcon G</pubmed_authors><pubmed_authors>Lopez-Reyes A</pubmed_authors><pubmed_authors>Martinez-Gomez L</pubmed_authors><pubmed_authors>Barbosa-Cobos RE</pubmed_authors></additional><is_claimable>false</is_claimable><name>The rs8176740 &lt;i>T/A&lt;/i> and rs512770 &lt;i>T/C&lt;/i> Genetic Variants of the &lt;i>ABO&lt;/i> Gene Increased the Risk of COVID-19, as well as the Plasma Concentration Platelets.</name><description>We conducted a case-control study in order to evaluate whether &lt;i>ABO&lt;/i> gene polymorphisms were associated with a high risk of developing COVID-19 in a cohort of patients. Six &lt;i>ABO&lt;/i> gene polymorphisms (rs651007 &lt;i>T&lt;/i>/&lt;i>C&lt;/i>, rs579459 &lt;i>T&lt;/i>/&lt;i>C&lt;/i>, rs495828 &lt;i>T/G&lt;/i>, rs8176746 &lt;i>A/C&lt;/i>, rs8176740 &lt;i>T/A&lt;/i>, and rs512770 &lt;i>T&lt;/i>/&lt;i>C&lt;/i>) were determined using TaqMan genotyping assays in a group of 415 COVID-19 patients and 288 healthy controls. The distribution of rs651007 &lt;i>T&lt;/i>/&lt;i>C&lt;/i>, rs579459 &lt;i>T&lt;/i>/&lt;i>C&lt;/i>, rs495828 &lt;i>T&lt;/i>/&lt;i>G&lt;/i>, and rs8176746 &lt;i>A&lt;/i>/&lt;i>C&lt;/i> polymorphisms was similar in patients and healthy controls. Nonetheless, under co-dominant (OR = 1.89, pC&lt;sub>Co-dominant&lt;/sub> = 6 × 10&lt;sup>-6&lt;/sup>), recessive (OR = 1.98, pC&lt;sub>Recessive&lt;/s</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-06-01T00:50:50.943Z</modification><creation>2024-11-13T11:05:35.397Z</creation></dates><accession>S-EPMC9027896</accession><cross_references><pubmed>35454075</pubmed><doi>10.3390/biom12040486</doi></cross_references></HashMap>